China Manufacturers >> Aipoc Meditech Co., Ltd. >>

Company Profile

Company Profile

Business Type: Manufacturer
Main Products:

IPL Beauty Equipment

,

Q-Switched ND: YAG Laser

,

RF Radio Frenquency Wrinkle Removal

,

Shr with Opt Technology

,

Hifu High Intensity Focus Untrasound

,

808nm Diode Laser Hair Removal

,

Cavitation with RF

,

Super Hair Removal System

,

Weight Lose Machine

,

Cavitation Ultrasound with RF Systems

Number of Employees: 6~10
Annual Turnover: US$10 Million - US$50 Million

Company Introduction

Aipoc Meditech Co., Ltd is a Sino-Canadian joint venture company specializing in manufacturing state-of-the-art aesthetic and medical devices. Aipoc have own outstanding OEM & ODM capability team, which can provide any design of operation interface and devices performance according to distributors and agents special requirement in a very short time.

Aipoc Meditech strickly according to the production and management standard of ISO 13485 and all the series have got the approval of Medical CE, which makes Aipoc Meditech enjoy a high reputation for developing quality products and for providing outstanding customer after sell service all over the world. Our product lines include the following 7 series.

1)IPL Series include SHR super hair removal with OPT technology

2)E-light Series, which is combined with IPL and RF function

3)Laser Series include Q-Switched ND: YAG laser, 808nm diode laser professional hair removal)

4)Ultrasound Cavitation with RF function Series

5)HIFU( High Intensity Focused Ultrasound ) Facing Lifting for face treatment Series,

6)Slimming Series

7)Microdermabrasion Series etc.

Aipoc's continually strive to produce new and innovative equipments to meet the requirement of our customers and the rapid development of the aesthetic and medical equipment industry. Our mission is to provide all the devices modular, cost-effective and high-performance devices systems that enable any practitioners to confidently offer safety, effective and profitable aesthetic treatments to their patients.